Measure ULA is reducing apartment development in the city of L.A, report says
The study, from researchers at UCLA and Rand, focuses on Measure ULA — a voter-approved law that took effect in spring 2023. Though dubbed the mansion tax, the measure applies a 4% levy to nearly all property sales in the city over about $5 million, including apartment buildings, mini-malls and warehouses, and a 5.5% charge to sales above about $10 million.
In doing so, the real estate industry has argued that the additional costs to the buying and selling of land have made it too difficult to earn a profit on many new housing developments, thus killing potential deals.
The study released Friday supports that view, with authors basing their findings on a drop-off in sales of property where multifamily homes are typically built.
In all, researchers estimated ULA is causing a reduction of at least 1,910 units per year. Because apartments in the city often are built using density bonuses that require private developers to include some income-restricted housing, there's also been a reduction of at least 168 affordable units annually, the report said.
"If we are building less housing, then the city is going to become even more unaffordable," said co-author Shane Phillips, the housing initiative project manager with UCLA's Lewis Center for Regional Policy Studies.
Los Angeles is not the only city where construction has fallen. Permits for new housing are down across the nation, as higher interest rates and material costs make it more difficult for developers to turn a profit.
ULA supporters have pointed to those rising costs to argue the measure isn't having the negative impact its real estate industry critics claim.
Report authors attempted to adjust for that dynamic by comparing land sales in the city of L.A. to other areas in the county where transfer taxes were not increased. They found land sales dropped much more in the city, and used the difference to come up with their estimate of lost units attributable to only ULA.
In a statement, Joe Donlin, director of the United to House LA coalition behind the tax, said the report was based on "highly questionable assumptions" and furthered the interests of "real estate millionaires and billionaires."
ULA backers have said in addition to interest rates, declining property sales may be attributed to some investors waiting it out while the real estate industry fights, so far unsuccessfully, to overturn ULA in court. They tout positive impacts the measure has brought.
In all, city data show the tax has raised nearly $633 million within two years. And the ULA coalition has said the has funded rental assistance for 11,000 Angelenos, paid for eviction defense and contributed money to the construction of 795 affordable homes.
ULA "has survived court challenges and referendum attempts from the real estate industry, and now, it's the largest source of affordable housing funding Los Angeles has ever seen," Donlin said.
However, Rand economist Jason Ward, who also authored the report, said the measure is hurting overall housing construction in several ways by extending beyond luxury home sales.
One, it reduces the number of land owners who want to sell in the first place, thus limiting opportunities to build. And many multifamily developers sell their projects to other investors after finishing construction, and would impacted by the tax again when doing so.
Even if developers plan to hold on to their new apartment buildings, they have mortgages on the property, and Ward said lenders must factor in the cost of a sale if the developer falls into foreclosure.
"They are going to either give you less money or give you money at a higher interest rate," said Ward, co-director of Rand's Center on Housing and Homelessness.
Ward and Phillips called for changes to the measure to limit its potential negative effects.
Not only do economists say that a reduction in market rate housing leads to higher rents, but the researchers argued that in the long run ULA will lead to a net loss in affordable units, as private developers of density bonus projects back away and ULA money isn't enough to back fill the hole.
The 795 affordable units cited by the coalition, for example, only received a minority share of funds from ULA, with other sources making up most of the project costs. Some projects had also already started construction before receiving ULA funds and needed more cash to finish after they experienced cost overruns.
Phillips and Ward said that while ULA likely sped up the construction of 795 units, those homes probably would have been built eventually as other sources were cobbled together and that more affordable units would be built without ULA.
To ensure more housing is built, the report recommended exempting from ULA multifamily projects built within in the last 15 years, which the authors say would only reduce annual ULA revenue by 8% at the most.
"Negative outcomes are not inevitable," the report reads, in calling for change.
The UCLA-Rand analysis follows a study released last week that found declining sales it attributed to ULA have led to a $25-million annual loss in property tax revenue, which will compound in coming years.
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
This story originally appeared in Los Angeles Times.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Los Angeles Times
6 hours ago
- Los Angeles Times
UCLA will negotiate with Trump over $339 million medical and science grant freezes
Since federal agencies surprised UCLA by freezing roughly $339 million in research grants, faculty, graduate workers and students have sought out details on what the university — the first public higher education institution targeted by President Trump — will do. Will UCLA challenge the federal government in court, negotiate and potentially pay a large fine or tap into emergency reserves to support researchers? With more than a third of its federal grant and contract funds frozen, will UCLA be forced to lay off employees, as Columbia, Harvard and other elite private universities did? As Trump battles to remake colleges, the administration has accused UCLA of illegally allowing antisemitism, using race in admissions and letting transgender players compete on sports teams that match their gender identity. Ivy League schools have similarly been faulted by the administration over their responses to pro-Palestinian encampments last year. Senior administrators outlined answers during a virtual town hall attended by about 3,000 faculty Monday and also at department-level meetings, including at the UCLA Medical School, which has lost hundreds of grants from the National Institutes of Health. But they cautioned that there were no final decisions. 'There is a time period to resolve the questions the government has for us,' Marcia L. Smith, associate vice chancellor for UCLA research administration, said during the virtual town hall. Smith said the leaders were 'preparing' to contact the NIH, National Science Foundation and the Department of Energy — which froze roughly 800 grants over several days last week — 'to talk about what kinds of information they need to lift these suspensions.' Smith said she was 'very hopeful' that UCLA will 'find a solution.' There was no mention of the University of California potentially making a payout like Columbia, which agreed last month to a more than $200 million fine as part of a sweeping agreement with Trump to restore suspended grants. UC as a system oversees federal relations for UCLA and nine other campuses. Speaking on background to The Times on Monday, three senior UC leaders echoed a similar message: UCLA will likely enter into negotiations, but it is too early to determine the terms. The officials were not authorized to speak publicly about internal deliberations. Negotiations would also not preclude a potential lawsuit, they said. 'Every single public institution in the nation is watching us very carefully,' UCLA vice chancellor for research Roger Wakimoto said during Monday's town hall. He later added: 'We're out of the gate setting the pace.' 'This is not just a UCLA decision, certainly our chancellor is going to be intimately involved in whatever path forward we decide, but it is also going to involve the regents of the University of California' Wakimoto said, as well as the new UC President James B. Milliken, who began the job Friday. Wakimoto and UCLA leaders also said other UC campuses were offering to help, including by taking care of lab animals that may need aid. The grant suspensions last week, affecting research into neuroscience, clean energy, cancer and other fields, came after the Justice Department and U.S. Atty. Gen. Pam Bondi said UCLA would pay a 'heavy price' for acting with 'deliberate indifference' to the civil rights of Jewish and Israeli students who complained of antisemitic incidents since Oct. 7, 2023. That's when Hamas attacked Israel, which led to Israel's war in Gaza and the pro-Palestinian student encampment on Royce Quad. The DOJ gave UCLA until Tuesdayto indicate it would negotiate over those findings. Otherwise, a letter to UC said the Trump administration would sue by Sept. 2. That letter was sent just a day before the federal agencies began notifying UCLA Chancellor Julio Frenk that vast portions of the university's research enterprise must come to a halt. In statements since last week, Frenk has challenged the idea that UCLA's alleged antisemitism is justification for pulling grants. 'A sweeping penalty on life-saving research doesn't address any alleged discrimination... We have contingency plans in place and we are doing everything we can,' Frenk said without elaborating on the plan. In a video posted to social media Monday, Milliken did not directly address suspensions but broadly mentioned the 'challenges' facing universities. 'Higher education is facing greater challenges and change than at any point in my career,' Milliken said. 'At the same time, I know that our work is essential to improving lives, strengthening the economy and providing lifesaving health care, more so than ever. The future of our state and our country and our world depend on thriving, innovative and accessible universities.' Hundreds of faculty have their own ideas. In a petition circulating across UCLA and UC campuses, professors are asking UC to challenge the government more head-on. A growing number have signed. 'We do not have to bend to the Trump administration's illegitimate and bad-faith demands... We demand in the strongest possible terms that the University of California demonstrate our strength as the world's largest university system and reject the malicious demands of the Trump administration,' said the petition from the UCLA Faculty Assn. As of Monday afternoon, the petition had garnered more than 600 signatures, mostly from UCLA professors. 'We demand that the UC name these demands as what they are: efforts to erode the strength of American higher education. Each university that falters legitimates the Trump administration's attacks on all of our institutions of higher education and we must stand up now. To protect our democracy we must protect our universities. Only when academic workers and the community as a whole collectively organize can we fight back against the threat to our campuses and our democracy,' the petition said. It also made another suggestion: that UC tap into billions in unrestricted endowment funds to bridge the gap left by suspended grants. University leaders have not publicly indicated whether that is on the table. Carrie Bearden, a professor at UCLA's Semel Institute for Neuroscience and Human Behavior and Brain Research Institute, is among those who signed. She is the director of a now-suspended five-year, $2.36-million NIH training grant that funds students doing neurogenetics research. 'That is an immediate, terrible impact on all the trainees. We do not know what other funding will cover them right now,' said Bearden, who said she was told by faculty leaders to potentially expect further grant cancellations, which is the way freezes took place at East Coast universities in recent months. Vivek Shetty, a UCLA professor of oral and maxillofacial surgery and biomedical engineering, also had an $828,154 four-year NIH grant frozen. His, which had been renewed over 11 years, focused on training digital health researchers, such as those who develop apps and wearables to flag irregular heartbeat, steer daily diabetes control and deliver medical care remotely. 'The funding freeze endangers the very care that will protect us and our families tomorrow,' said Shetty, a former UCLA Academic Senate chair. 'Starve these brilliant minds today, and we extinguish an entire generation of life-saving ideas. However fierce its public objections, the University of California will likely acquiesce to Washington's terms, painfully aware of the deep human and scientific costs of this harsh decree.'


Fox News
12 hours ago
- Fox News
California officials are using taxpayer money for 'political purposes,' says Dr. Houman Hemmati
'Fox News @ Night' panelists Julie Hamill and Dr. Houman Hemmati discuss California officials' legal wins against the Trump administration and a federal funding freeze to UCLA.


Business Wire
a day ago
- Business Wire
Rand Capital Reports Second Quarter 2025 Results
BUFFALO, N.Y.--(BUSINESS WIRE)-- Rand Capital Corporation (Nasdaq: RAND) ('Rand' or the 'Company'), a business development company providing alternative financing for lower middle market companies, announced its results for the second quarter ended June 30, 2025. 'We delivered net investment income growth in the second quarter, primarily benefiting from a non-cash capital gains incentive fee reversal tied to the write-down of our investment in Tilson,' said Daniel P. Penberthy, President and Chief Executive Officer of Rand. 'At the same time, total investment income declined due to the continued impact of portfolio loan repayments that have not yet been offset by new investments. Investment activity remains slower than desired amid ongoing economic uncertainty, which has led more borrowers to pay interest 'in kind' (PIK) by increasing their loan balances rather than using cash during the first half of 2025. As a result, over $1.2 million of interest was added to the principal of our portfolio obligations, representing approximately 34% of our total investment income.' Mr. Penberthy added, 'We are starting to see early signs of market improvement, which could return portions of our portfolio to current pay status and lead to stronger deal origination and execution. With approximately $25 million in total liquidity and no debt outstanding, we believe we are well-positioned to support our dividend and act quickly on new investment opportunities as conditions evolve.' Second Quarter Highlights (compared with the prior-year period unless otherwise noted) Total investment income was $1.6 million, a decrease of $534,000, or 25%, compared with the same period last year. The change was primarily driven by a 24% reduction in interest income from portfolio companies, reflecting the repayment of five debt instruments over the past year. Lower dividend income also contributed to the year-over-year decrease. Total expenses were a benefit of $864,000 compared with an expense of $2.7 million in the same period last year. This improvement was primarily driven by a $3.1 million reduction in capital gains incentive fee expense. In the second quarter of 2025, Rand recorded a $1.5 million capital gains incentive fee benefit, reflecting a net increase in unrealized depreciation, whereas the prior-year period included a $1.6 million expense. Additionally, lower average outstanding debt balances led to a $368,000 reduction in interest expense, and base management fees declined by $105,000 due to portfolio company principal repayments and valuation adjustments. Adjusted expenses, which exclude capital gains incentive fees, and is a non-GAAP financial measure, were $626,000 compared with $1.0 million in the second quarter of 2024. See the attached description of this non-GAAP financial measure and reconciliation table for adjusted expenses. Net investment income increased to $2.5 million, or $0.83 per share, compared with a loss of $517,000, or $0.20 per share, in the second quarter of 2024. Adjusted net investment income per share, a non-GAAP financial measure, which excludes the capital gains incentive fee, was $0.33 per share, compared with $0.44 per share in last year's second quarter. The second quarter of 2025 per share amounts were computed using 2,969,814 weighted average shares outstanding, reflecting a higher number of shares outstanding following the fourth quarter 2024 dividend, distributed in the first quarter of 2025, that was paid in part using shares of common stock. This compared with 2,581,021 weighted average shares outstanding for the second quarter of 2024. See the attached description of this non-GAAP financial measure and reconciliation table for adjusted net investment income per share. Portfolio and Investment Activity As of June 30, 2025, Rand's portfolio included investments with a fair value of $52.4 million across 19 portfolio businesses. This was a decrease of $18.5 million, or 26%, from December 31, 2024, primarily due to portfolio company loan repayments and valuation adjustments in multiple portfolio companies. The portfolio was comprised of approximately 86% debt investments and 14% equity investments at June 30, 2025. The annualized weighted average yield of debt investments, which includes PIK interest, was 12.2% at June 30, 2025, compared with 13.8% at the end of 2024. Second Quarter 2025: Funded a follow-on equity investment of $35,000 in Carolina Skiff LLC. Rand's total equity investment in Carolina Skiff had a fair value of $800,000 at quarter-end. The valuation of Rand's investment in Tilson Technologies decreased $9.5 million after it filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court, District of Delaware. Additional information regarding the Tilson Technologies bankruptcy can be found in Rand's Current Report on Form 8-K filed on May 30, 2025. Liquidity and Capital Resources Rand ended the quarter with $4.4 million in cash, an increase from $835,000 at year-end 2024. As of June 30, 2025, there was no outstanding balance on the Company's senior secured revolving credit facility. Mr. Penberthy stated, 'While the borrowing base formula provided approximately $20 million of unused availability as of June 30, 2025, we have the capacity to increase this to a total of $25 million, subject to certain borrowing criteria and portfolio eligibility requirements through its 2027 maturity.' The Company did not repurchase any outstanding common stock during the second quarter of 2025. Dividends On April 30, 2025, Rand declared its regular quarterly cash dividend of $0.29 per share, which was paid during the second quarter to shareholders of record as of May 30, 2025. On July 28, 2025, Rand declared its regular quarterly cash dividend of $0.29 per share. The cash dividend will be distributed on or about September 12, 2025, to shareholders of record as of August 29, 2025. Webcast and Conference Call Rand will host a conference call and webcast on Monday, August 4, 2025, at 1:30 p.m. Eastern Time, to review its financial results. The review will be accompanied by a slide presentation, which will be available on Rand's website at in the 'Investor Relations' section. Rand's conference call can be accessed by calling (201) 689-8263. Alternatively, the webcast can be monitored on Rand's website at under 'Investors' where the replay will also be available. A telephonic replay will be available from 5:30 p.m. ET on the day of the call through Monday, August 18, 2025. To listen to the archived call, dial (412) 317-6671 and enter replay pin 13754384. A transcript of the call will also be posted once available. ABOUT RAND CAPITAL Rand Capital Corporation (Nasdaq: RAND) is an externally managed business development company (BDC). The Company's investment objective is to maximize total return to its shareholders with current income and capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. Rand primarily invests in businesses that have sustainable, differentiated and market-proven products, revenue of more than $10 million and EBITDA in excess of $1.5 million. The Company's investment activities are managed by its external investment adviser, Rand Capital Management, LLC. Additional information can be found at the Company's website where it regularly posts information: Safe Harbor Statement This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than historical facts, including but not limited to statements regarding the strategy of the Company and its outlook; statements regarding the implementation of the Company's strategy and the growth of its dividend; statements regarding the impact of market improvements on returning portions of the debt portfolio to current pay status; and any assumptions underlying any of the foregoing, are forward-looking statements. Forward-looking statements concern future circumstances and results and other statements that are not historical facts and are sometimes identified by the words 'may,' 'will,' 'should,' 'potential,' 'intend,' 'expect,' 'endeavor,' 'seek,' 'anticipate,' 'estimate,' 'overestimate,' 'underestimate,' 'believe,' 'could,' 'project,' 'predict,' 'continue,' 'target' or other similar words or expressions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) evolving legal, regulatory and tax regimes; (2) changes in general economic and/or industry specific conditions; and (3) other risk factors as detailed from time to time in Rand's reports filed with the Securities and Exchange Commission ('SEC'), including Rand's annual report on Form 10-K for the year ended December 31, 2024, quarterly reports on Form 10-Q, and other documents filed with the SEC. Consequently, such forward-looking statements should be regarded as Rand's current plans, estimates and beliefs. Except as required by applicable law, Rand assumes no obligation to update the forward-looking information contained in this release. FINANCIAL TABLES FOLLOW Rand Capital Corporation and Subsidiaries June 30, 2 025 (Unaudited) 2 024 ASSETS Investments at fair value: Control investments (cost of $6,563,940 and $6,188,940, respectively) $ 2,000,000 $ 2,500,000 Affiliate investments (cost of $44,800,334 and $42,488,804, respectively) 42,717,475 51,668,144 Non-Control/Non-Affiliate investments (cost of $9,912,772 and $19,442,491, respectively) 7,646,779 16,649,897 52,364,254 70,818,041 Cash 4,419,813 834,805 Interest receivable (net of allowance of $25,337 and $0, respectively) 250,263 357,530 Prepaid income taxes 344,695 329,365 Deferred tax asset, net 111,438 2,161 Other assets 149,076 115,531 Total assets $ 57,639,539 $ 72,457,433 LIABILITIES AND STOCKHOLDERS' EQUITY (NET ASSETS) Liabilities: Due to investment adviser $ 509,500 $ 2,182,846 Accounts payable and accrued expenses 38,600 92,568 Line of credit — 600,000 Capital gains incentive fees — 1,565,000 Deferred revenue 377,485 516,441 Dividend payable — 2,168,058 Total liabilities 925,585 7,124,913 Stockholders' equity (net assets): Common stock, $0.10 par; shares authorized 100,000,000; shares issued: 3,037,709 at 6/30/25 and 2,648,916 at 12/31/24; shares outstanding: 2,969,814 at 6/30/25 and 2,581,021 at 12/31/24 303,771 264,892 Capital in excess of par value 64,051,504 55,419,620 Stock dividends distributable: 0 shares at 6/30/25 and 388,793 shares at 12/31/24 — 8,672,231 Treasury stock, at cost: 67,895 shares at 6/30/25 and 12/31/24 (1,566,605 ) (1,566,605 ) Total distributable earnings (6,074,716 ) 2,542,382 Total stockholders' equity (net assets) (per share – 6/30/25: $19.10; 12/31/24: $25.31) 56,713,954 65,332,520 Total liabilities and stockholders' equity (net assets) $ 57,639,539 $ 72,457,433 Expand Rand Capital Corporation and Subsidiaries Consolidated Statements of Operations (Unaudited) Investment income: Interest from portfolio companies: Control investments $ 12,979 $ 198,885 $ 12,979 $ 386,368 Affiliate investments 1,264,789 1,192,116 2,547,648 2,358,201 Non-Control/Non-Affiliate investments 236,794 604,226 631,101 1,064,306 Total interest from portfolio companies 1,514,562 1,995,227 3,191,728 3,808,875 Interest from other investments: Non-Control/Non-Affiliate investments 36,556 144 46,939 2,058 Total interest from other investments 36,556 144 46,939 2,058 Dividend and other investment income: Affiliate investments — 13,125 13,125 26,250 Non-Control/Non-Affiliate investments — 60,050 — 198,760 Total dividend and other investment income — 73,175 13,125 225,010 Fee income: Control investments 4,516 4,516 9,032 9,032 Affiliate investments 42,891 54,815 174,646 128,535 Non-Control/Non-Affiliate investments 3,772 8,272 174,731 29,858 Total fee income 51,179 67,603 358,409 167,425 Total investment income 1,602,297 2,136,149 3,610,201 4,203,368 Expenses: Base management fee 217,649 322,672 469,857 625,267 Income based incentive fees — — 119,673 — Capital gains incentive fees (1,490,000 ) 1,641,000 (1,565,000 ) 1,753,300 Interest expense 25,417 393,172 61,903 783,192 Professional fees 142,020 91,460 350,862 323,767 Stockholders and office operating 103,349 82,667 194,112 151,695 Directors' fees 66,550 66,550 130,400 130,400 Administrative fees 50,250 40,000 99,000 78,167 Insurance 9,974 10,380 23,136 23,424 Corporate development (2,493 ) 4,881 4,501 10,426 Bad debt expense 13,125 — 38,462 — Total (benefits) expenses (864,159 ) 2,652,782 (73,094 ) 3,879,638 Net investment income (loss) before income taxes: 2,466,456 (516,633 ) 3,683,295 323,730 Income tax (benefit) expense (11,778 ) 562 (13,054 ) 1,340 Net investment income (loss) 2,478,234 (517,195 ) 3,696,349 322,390 Net realized gain (loss) on sales and dispositions of investments: Affiliate investments — (831,891 ) 925,357 (831,891 ) Non-Control/Non-Affiliate investments — 1,259,999 (25 ) 4,710,091 Net realized gain (loss) on sales and dispositions of investments — 428,108 925,332 3,878,200 Net change in unrealized appreciation/depreciation on investments: Control investments — — (875,000 ) — Affiliate investments (10,122,270 ) 8,849,945 (10,545,654 ) 8,749,945 Non-Control/Non-Affiliate investments (189,944 ) (1,070,919 ) (189,944 ) (3,861,215 ) Change in unrealized appreciation/depreciation before income taxes (10,312,214 ) 7,779,026 (11,610,598 ) 4,888,730 Deferred income tax benefit (97,826 ) (47,834 ) (94,210 ) (47,834 ) Net change in unrealized appreciation/depreciation on investments (10,214,388 ) 7,826,860 (11,516,388 ) 4,936,564 Net realized and unrealized (loss) gain on investments (10,214,388 ) 8,254,968 (10,591,056 ) 8,814,764 Net (decrease) increase in net assets from operations $ (7,736,154 ) $ 7,737,773 $ (6,894,707 ) $ 9,137,154 Weighted average shares outstanding 2,969,814 2,581,021 2,920,135 2,581,021 Basic and diluted net (decrease) increase in net assets from operations per share $ (2.60 ) $ 3.00 $ (2.36 ) $ 3.54 Expand Rand Capital Corporation and Subsidiaries Consolidated Statements of Changes in Net Assets (Unaudited) Three months ended June 30, 2025 Three months ended June 30, 2024 Six months ended June 30, 2025 Six months ended June 30, 2024 Net assets at beginning of period $ 65,311,253 $ 61,569,339 $ 65,332,520 $ 60,815,213 Net investment income (loss) 2,478,234 (517,195 ) 3,696,349 322,390 Net realized gain on sales and dispositions of investments — 428,108 925,332 3,878,200 Net change in unrealized appreciation/depreciation on investments (10,214,388 ) 7,826,860 (11,516,388 ) 4,936,564 Net (decrease) increase in net assets from operations (7,736,154 ) 7,737,773 (6,894,707 ) 9,137,154 Declaration of dividend (861,145 ) (748,496 ) (1,723,859 ) (1,393,751 ) Net assets at end of period $ 56,713,954 $ 68,558,616 $ 56,713,954 $ 68,558,616 Expand Rand Capital Corporation and Subsidiaries Reconciliation of GAAP Total Expense to Non-GAAP Adjusted Expenses (Unaudited) In addition to reporting total expenses, which is a U.S. generally accepted accounting principle ('GAAP') financial measure, Rand presents adjusted expenses, which is a non-GAAP financial measure. Adjusted expenses is defined as GAAP total expenses removing the effect of any (credits)/expenses for capital gains incentive fees accrual. GAAP total expenses is the most directly comparable GAAP financial measure. Rand believes that adjusted expenses provides useful information to investors regarding financial performance because it is a method the Company uses to measure its financial and business trends related to its results of operations. The presentation of this additional information is not meant to be considered in isolation or as a substitute for financial results prepared in accordance with GAAP. Reconciliation of GAAP Net Investment Income (Loss) per Share to Adjusted Net Investment Income per Share (Unaudited) In addition to reporting Net Investment Income (Loss) per Share, which is a GAAP financial measure, the Company presents Adjusted Net Investment Income per Share, which is a non-GAAP financial measure. Adjusted Net Investment Income per Share is defined as GAAP Net Investment Income per Share removing the effect of any (credits)/expenses for capital gains incentive fees. GAAP Net Investment Income per Share is the most directly comparable GAAP financial measure. Rand believes that Adjusted Net Investment Income per Share provides useful information to investors regarding financial performance because it is a method the Company uses to measure its financial and business trends related to its results of operations. The presentation of this additional information is not meant to be considered in isolation or as a substitute for financial results prepared in accordance with GAAP. The per share amounts for the three and six months ended June 30, 2025 were computed using 2,969,814 and 2,920,135 weighted average shares outstanding, respectively, reflecting a higher number of shares outstanding following the fourth quarter 2024 dividend, which was paid in part using shares of common stock. This compared with 2,581,021 weighted average shares outstanding for the three and six months ended June 30, 2024.